Research and Markets: Global H1N1 Infection Pipeline Review H2 2015

Research and Markets (http://www.researchandmarkets.com/research/472fp3/h1n1_infection) has announced the addition of the "H1N1 Infection - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for H1N1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for H1N1 Infection and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Adamas Pharmaceuticals, Inc.
  • Akshaya Bio Inc.
  • Altimmune, Inc.
  • Antigen Express, Inc.
  • Beijing Minhai Biotechnology Co., Ltd
  • CEL-SCI Corporation
  • Cilian AG
  • Crucell N.V.
  • CSL Limited
  • EpiVax, Inc.
  • Etubics Corporation
  • Gemmus Pharma Inc.
  • iBio, Inc.
  • ILiAD Biotechnologies, LLC
  • Inovio Pharmaceuticals, Inc.
  • Kineta, Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • Medicago Inc.
  • Microbiotix, Inc.
  • Mucosis B.V.
  • NanoViricides, Inc.
  • NewLink Genetics Corporation
  • Onxeo SA
  • OPKO Health, Inc.
  • PDS Biotechnology Corporation
  • REPLICor Inc.
  • Sarepta Therapeutics, Inc.
  • Sirnaomics, Inc.
  • TaiMed Biologics Inc.
  • Takeda Pharmaceutical Company Limited
  • TechnoVax, Inc.
  • Touchlight Genetics Limited
  • United Therapeutics Corporation
  • Vaxart, Inc.
  • Visterra, Inc.

For more information visit http://www.researchandmarkets.com/research/472fp3/h1n1_infection

Contacts:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases, Biodefense

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.